Removing the financial penalties associated with the Affordable Care Act's individual mandate may cause enrollment to fall by 2.8 to 13 million people, and a 3 to 13 percent increase in bronze plan premiums.
Assessing whether networked risk assessments match the actual cascades that occur during disasters can provide a process for further refinement of assessment tools by uncovering their strengths and weaknesses.
California's Return-to-Work Supplement Program provides a $5,000 payment to some workers who cannot return to work after a permanently disabling workplace injury. RAND researchers evaluated program performance and identified options for improvement.
What are the challenges and opportunities for the automobile insurance industry as autonomous vehicle technology becomes widely deployed? This workshop brought together industry stakeholders, regulators, and consumer representatives to focus on the implications of AV technology for insurance and liability regimes.
This report assesses the Survivor Benefit Plan in terms of participation and benefits, compares it with similar plans in public and private organizations, and considers the feasibility of having the plan provided by commercial sources.
Following Medicaid expansion, non safety-net hospitals experienced a greater percentage increase in Medicaid stays than did safety-net hospitals, which may reflect patient choice or a crowd-out of private insurance.
The new tax law eliminates the individual mandate. When this repeal takes effect in 2019, millions more Americans are expected to go without health insurance. Auto insurers will likely pick up the tab for some of that population's medical care. That could raise car insurance premiums.
The Official Disability Guidelines (ODG) Medical Treatment Guidelines are an important resource for workers' compensation systems because they can be used to contain medical care costs while assuring appropriate care is provided.
The National Institute for Occupational Safety and Health (NIOSH) asked the RAND Corporation to develop an approach for estimating the economic benefit of NIOSH research, using three case studies. A new report details findings and recommendations.
This report assesses California workers' compensation-required reports -- including the structure and content, level of effort, and allowances -- and compares the elements and processes with other systems to inform potential improvements.
This report reviews various alternatives to relying exclusively on traditional civil litigation to assign responsibility for the human causes of a catastrophe and to determine the types of losses that a designated responsible party must reimburse.
Policymakers have many options to expand coverage in the individual market. We considered federal investments that would enhance, extend, or increase the tax credits available to enrollees, as well as reinsurance approaches that would lower premiums.
Introducing “biosimilar” versions of complex biologic drugs used to treat illnesses such as cancer and rheumatoid arthritis could cut health care spending in the United States by $54 billion over the next decade.
Biologics are complex drugs used to treat rheumatoid arthritis, cancer, and other diseases. They accounted for 70 percent of the growth in U.S. prescription drug spending between 2010 and 2015. Biosimilar versions of biologics could cut health care costs by $54 billion over the next decade.
This report uses RAND's COMPARE microsimulation model to estimate the effects of a 1332 waiver application from the state of Iowa. The waiver is designed to stabilize Iowa's Affordable Care Act individual market through a series of modifications.